RU2011116948A - METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR - Google Patents

METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR Download PDF

Info

Publication number
RU2011116948A
RU2011116948A RU2011116948/15A RU2011116948A RU2011116948A RU 2011116948 A RU2011116948 A RU 2011116948A RU 2011116948/15 A RU2011116948/15 A RU 2011116948/15A RU 2011116948 A RU2011116948 A RU 2011116948A RU 2011116948 A RU2011116948 A RU 2011116948A
Authority
RU
Russia
Prior art keywords
growth factor
endothelial dysfunction
antibody
correction
vascular endothelium
Prior art date
Application number
RU2011116948/15A
Other languages
Russian (ru)
Other versions
RU2526151C2 (en
Inventor
Александр Сергеевич Белоус (RU)
Александр Сергеевич Белоус
Михаил Владимирович Покровский (RU)
Михаил Владимирович Покровский
Татьяна Григорьевна Покровская (RU)
Татьяна Григорьевна Покровская
Виктор Сергеевич Белоус (RU)
Виктор Сергеевич Белоус
Анна Александровна Арустамова (RU)
Анна Александровна Арустамова
Олег Сергеевич Гудырев (RU)
Олег Сергеевич Гудырев
Михаил Викторович Корокин (RU)
Михаил Викторович Корокин
Елена Станиславовна Черноморцева (RU)
Елена Станиславовна Черноморцева
Олег Ильич Эпштейн (RU)
Олег Ильич Эпштейн
Светлана Александровна Сергеева (RU)
Светлана Александровна Сергеева
Юлия Александровна Заболотнева (RU)
Юлия Александровна Заболотнева
Original Assignee
Общество с ограниченной ответственностью "Научно-производственная фирма "Материа Медика Холдинг" (RU)
Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Научно-производственная фирма "Материа Медика Холдинг" (RU), Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" filed Critical Общество с ограниченной ответственностью "Научно-производственная фирма "Материа Медика Холдинг" (RU)
Priority to RU2011116948/15A priority Critical patent/RU2526151C2/en
Publication of RU2011116948A publication Critical patent/RU2011116948A/en
Application granted granted Critical
Publication of RU2526151C2 publication Critical patent/RU2526151C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к фактору роста сосудистого эндотелия, отличающийся тем, что в эксперименте крысам самцам линии Wistar в течение 28 дней, на фоне внутрибрюшинного введения L-Name в дозе 12,5 мг/кг, ежедневно, 2 раза в сутки по 4,5 мл/кг (9 мл/кг/сут), внутрижелудочно, вводят смесь растворов гомеопатических разведении моноклональных антител к фактору роста сосудистого эндотелия (VEGF) - С12, С30, С200. A method for correcting endothelial dysfunction with a solution of homeopathic dilutions of antibodies to vascular endothelial growth factor, characterized in that in the experiment, rats of Wistar males for 28 days, against the background of intraperitoneal administration of L-Name at a dose of 12.5 mg / kg, daily, 2 times a day at 4.5 ml / kg (9 ml / kg / day), intragastrically, a mixture of solutions of homeopathic dilution of monoclonal antibodies to vascular endothelial growth factor (VEGF) is administered - C12, C30, C200.

Claims (1)

Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к фактору роста сосудистого эндотелия, отличающийся тем, что в эксперименте крысам самцам линии Wistar в течение 28 дней, на фоне внутрибрюшинного введения L-Name в дозе 12,5 мг/кг, ежедневно, 2 раза в сутки по 4,5 мл/кг (9 мл/кг/сут), внутрижелудочно, вводят смесь растворов гомеопатических разведении моноклональных антител к фактору роста сосудистого эндотелия (VEGF) - С12, С30, С200. A method for correcting endothelial dysfunction with a solution of homeopathic dilutions of antibodies to vascular endothelial growth factor, characterized in that in the experiment, rats of Wistar males for 28 days, against the background of intraperitoneal administration of L-Name at a dose of 12.5 mg / kg, daily, 2 times a day at 4.5 ml / kg (9 ml / kg / day), intragastrically, a mixture of solutions of homeopathic dilution of monoclonal antibodies to vascular endothelial growth factor (VEGF) is administered - C12, C30, C200.
RU2011116948/15A 2011-04-28 2011-04-28 Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies RU2526151C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011116948/15A RU2526151C2 (en) 2011-04-28 2011-04-28 Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011116948/15A RU2526151C2 (en) 2011-04-28 2011-04-28 Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies

Publications (2)

Publication Number Publication Date
RU2011116948A true RU2011116948A (en) 2012-11-10
RU2526151C2 RU2526151C2 (en) 2014-08-20

Family

ID=47321874

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011116948/15A RU2526151C2 (en) 2011-04-28 2011-04-28 Method for correction of endothelial dysfunction by solution of homoeopathic dilutions of vascular endothelial growth factor antibodies

Country Status (1)

Country Link
RU (1) RU2526151C2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007067807A1 (en) * 2005-12-07 2007-06-14 Alacrity Biosciences, Inc. Tetracyclines for treating ocular diseases and disorders

Also Published As

Publication number Publication date
RU2526151C2 (en) 2014-08-20

Similar Documents

Publication Publication Date Title
PE20190262A1 (en) METHODS FOR TREATING CANCER BY USE OF PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS
RS52452B (en) Antibodies and immunoconjugates and uses thereof
PE20142167A1 (en) ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES
PE20150025A1 (en) ANTIBODIES AND IMMUNOCONJUGATES AGAINST LY6E AND METHODS OF USE
MX2018012648A (en) Antibody-containing preparation.
AR096364A1 (en) ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE
UA116189C2 (en) FORMULATION FOR ANTI-α4β7 ANTIBODY
EA201792652A3 (en) NEW DERIVATIVES OF MAYTANZINOIDS WITH PEPTIDE LINKER AND THEIR CONJUGATES
PE20181009A1 (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE OF THEM
PE20141413A1 (en) ANTIBODY FORMULATIONS AND METHODS
PE20120899A1 (en) COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C3B
PE20142170A1 (en) ANTIBODIES AGAINST BRADYCININ B1 RECEPTOR LIGANDS
PE20120080A1 (en) ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE
RU2015102069A (en) ANTIBODIES TO BIOTIN AND WAYS OF THEIR APPLICATION
MX359263B (en) Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease.
EA201490756A1 (en) CITRAMID RAZAGLININA
PE20141706A1 (en) TROMBINA UNION ANTIBODIES AND USES OF THE SAME
JP2013535483A5 (en)
RU2011116948A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR
RU2011116945A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODIES HOMEOPATHIC DILUTION TO TUMOR-ALPHA NECROSIS FACTOR
RU2011116946A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO INTERLEUKIN-1
RU2011116949A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO ENDOTHELIAL SYNTHESIS OF HUMAN NITROGEN OXIDE
PE20131328A1 (en) ANTI-VEGFR-3 ANTIBODY COMPOSITIONS
RU2011116947A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO THE C-END Fragment of the Angiotensin II Receptor
RU2011116944A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO INTERLEUKIN-6

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20130116

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20140116

MM4A The patent is invalid due to non-payment of fees

Effective date: 20150429